Positron emission mammography

From Wikipedia, the free encyclopedia
Jump to: navigation, search
Positron emission mammography
Diagnostics
ICD-10-PCS CH3

Positron emission mammography (PEM) is a modality used to detect breast cancer.[1]

It is approved (by US FDA) for patients with a history of breast cancer.[2]

PEM uses a pair of gamma radiation detectors placed above and below the breast and mild breast compression to detect coincident gamma rays after administration of the radionuclide fluorine-18 fluorodeoxyglucose (18F-FDG), as used in whole-body PET studies for the detection of metastatic disease.[3]

References[edit]

  1. ^ "Clinical imaging characteristics of the positron emission mammography camera: PEM Flex Solo II". J. Nucl. Med. 50 (10): 1666–75. October 2009. doi:10.2967/jnumed.109.064345. PMC 2873041. PMID 19759118. 
  2. ^ Tartar, Marie; Comstock, Christopher E.; Kipper, Michael S. (2008). Breast cancer imaging: a multidisciplinary, multimodality approach. Elsevier Health Sciences. pp. 88–. ISBN 978-0-323-04677-0. Retrieved 18 July 2011. 
  3. ^ Glass and Shah (2013). "Clinical utility of positron emission mammography". Proc (Bayl Univ Med Cent) 26: 314–9. PMC 3684309. PMID 23814402. 

 This article incorporates public domain material from the U.S. National Cancer Institute document "Dictionary of Cancer Terms".